Eravacycline for Mycobacterium abscessus infections: pharmacodynamic advantages of long-acting post-antibiotic effects and weekly dosing regimens

ABSTRACT Mycobacterium abscessus (MAB) is one of the most common non-tuberculous mycobacteria with an extremely high resistance rate to classic anti-tuberculosis drugs. This study aimed to evaluate the activities of the novel tetracycline agent eravacycline (ERC) against MAB using clinical isolates...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Ruoyan Ying, Guoling Yang, Xiaochen Huang, Jie Wang, Li Wang, Wei Sha
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	American Society for Microbiology 2026-05-01
Цуврал:	Microbiology Spectrum
Нөхцлүүд:	Mycobacterium abscessus eravacycline PAE PA-SME pulmonary infection
Онлайн хандалт:	https://journals.asm.org/doi/10.1128/spectrum.01473-25
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!